top of page

Remidio Appointed as Exclusive Distribution Partner for Occuity’s Ophthalmic Devices in India

  • Writer: Richard Kadri-Langford
    Richard Kadri-Langford
  • May 13
  • 2 min read

Occuity, is pleased to announce that Remidio Innovative Solutions, a leading manufacturer and distributor of ophthalmic medical devices, has been appointed as its exclusive distribution partner in India.

 

This new partnership will see Remidio bringing Occuity’s revolutionary ophthalmic technologies, starting with the PM1 Pachymeter, to eye care professionals across India, improving access to innovative, non-invasive diagnostic solutions.

 

Strengthening Eye Care Through Non-Contact Innovation

 

India faces growing demands in eye health services, particularly in detecting and managing conditions such as glaucoma. In response, Remidio will distribute Occuity’s PM1 Pachymeter, a handheld, non-contact optical device that measures corneal thickness—a critical parameter in glaucoma diagnosis and management.

  

Dr Anand Sivaraman, CEO of Remidio, commented: "


We are excited to bring Occuity’s innovative technology to the Indian market. The PM1 Pachymeter is just the beginning—there is enormous potential to enhance the quality and accessibility of eye care across India."

 

A Shared Vision for Accessible, High-Quality Eye Care

 

Both Occuity and Remidio share a commitment to improving patient outcomes through technology. By combining Occuity’s expertise in optical diagnostics with Remidio’s deep understanding of the Indian healthcare landscape, this partnership is poised to expand access to cutting-edge eye care solutions across the region.

 

Dan Daly, CEO and Co-Founder of Occuity, added:


"Remidio’s strong reputation and proven track record in India make them the ideal partner to introduce our ophthalmic devices to clinicians and patients. We look forward to working closely together to support the advancement of non-contact eye health technologies."

 

Demonstrating at APOA 2025

 

The PM1 Pachymeter was launched to the Indian market by Remidio at the 40th Asia-Pacific Academy of Ophthalmology (APAO) Congress, held in the vibrant city of New Delhi on April 3 to 6.




 

About Occuity

Founded in 2019, Occuity specialises in the design and manufacture of non-contact, handheld devices for the healthcare sector. Its first product, the PM1 Pachymeter, is the world’s first handheld, non-contact optical pachymeter, designed to improve diagnostic accuracy and enhance patient comfort.

Learn more at www.occuity.com.

 

About Remidio

Remidio Innovative Solutions is a global leader in ophthalmic medical devices, renowned for developing accessible, high-quality technologies that enable early detection and treatment of eye diseases. With a strong focus on portability, affordability, and impact, Remidio’s solutions are used by clinicians across more than 30 countries to combat preventable blindness.

Comments


bottom of page